The British journal of psychiatry : the journal of mental science
Audio Summaries

Using point allocation to identify outcomes that matter: results from two cognitive behavioural therapy trials for depression

Sep 18, 2026

The authors aimed to identify and prioritize outcome domains that are important to stakeholders—service users with minimal and current symptoms of depression, as well as clinicians—beyond traditional symptom-based measures in cognitive behavioral therapy (CBT) trials. Through an online survey using a point-allocation method, they found that stakeholders valued depression symptoms alongside quality of life and anxiety symptoms, highlighting the need for trial designs that incorporate these broader outcomes to better reflect stakeholder perspectives.

Dopamine antagonists and dynamic symptom networks in schizophrenia

Sep 14, 2026

This study investigates how a 6-week treatment with the antipsychotic paliperidone affects the structure of symptom networks in individuals with schizophrenia. The authors found that antipsychotic treatment significantly reduced both overall symptom severity and the connectivity among symptoms, indicating that effective treatment disrupts maladaptive interactions between symptoms. These results provide insights into the mechanisms of clinical improvement and highlight potential targets for future interventions.

Beyond stigma: reframing antipsychotics as medical treatment

Sep 14, 2026

The authors investigate how reframing antipsychotics as essential medical treatment can address the issue of non-adherence, which is often exacerbated by stigma. They highlight the benefits of sustained antipsychotic treatment, including reduced mortality and improved quality of life, suggesting that changing the perception of these medications may enhance patient engagement and outcomes in severe mental illness.

Self-harm as ritual: evolutionary perspective

Sep 14, 2026

The authors investigate whether group self-harm among young people can be understood as an ancient ritual process, using Tinbergen's four questions from evolutionary biology as a framework. They suggest that this behavior has become harmful due to its disconnection from the cultural structures that historically provided context and meaning.

Psychotropic medications in mood disorders: to deprescribe or not?

Sep 14, 2026

The authors explore the question of whether to deprescribe psychotropic medications in patients with mood disorders, addressing the growing interest and need for guidance in this area. They summarize key recommendations for implementing deprescribing strategies and discuss how these can be integrated into various clinical contexts.

Immune dysregulation in depression and psychosis: summary of current evidence and future perspectives

Sep 8, 2026

The authors investigate the relationship between immune dysregulation and mental health disorders, specifically depression and schizophrenia, highlighting the ongoing debate over causality and the lack of clinically useful immune biomarkers. They suggest that new methodological approaches, such as target trial emulation and functional genomics, may pave the way for advancements in precision immunopsychiatry and tailored immunomodulatory treatments.

Cognitive overload in the Attention Economy

Sep 7, 2026

The authors investigate the rising rates of adult diagnoses of attention-deficit hyperactivity disorder (ADHD) and question whether current diagnostic frameworks can effectively differentiate between neurodevelopmental and environmentally induced attentional deficits. They argue for the need for a revised clinical framework in psychiatry that takes into account the effects of the modern information environment on cognitive functioning, drawing parallels to the precision achieved by the advertising industry.

Rethinking the Edinburgh Postnatal Depression Scale: contemporary relevance, validity and implications for future research

Sep 7, 2026

The authors examine the relevance and validity of the Edinburgh Postnatal Depression Scale in light of modern understandings of perinatal mental health. They advocate for a comprehensive revision of the scale to improve its inclusivity and clinical utility, aiming to enhance the accuracy of assessments in contemporary care settings.

Trajectories of physical comorbidity burden and all-cause mortality in people with severe mental illness: joint latent class modelling study with up to 10 years of follow-up

Sep 7, 2026

The authors aimed to identify distinct trajectories of physical comorbidity burden and their association with all-cause mortality in individuals with severe mental illness (SMI). By analyzing data from 64,962 patients over up to 10 years, they identified four trajectory groups, each linked to varying mortality risks, highlighting the importance of routine primary care indicators for early identification of higher-risk patients. The study underscores the need for prospective validation of these findings to inform risk-stratified interventions.

Conceptual challenges in psychiatric nosology: ADHD across six editions of the DSM

Sep 7, 2026

This article by Yaakov Ophir explores the conceptual challenges in psychiatric nosology, specifically focusing on attention-deficit hyperactivity disorder (ADHD) across six editions of the DSM. The author aims to address key classification issues such as prevalence thresholds, gender differences, and comorbidity, highlighting how diagnostic revisions may impact the coherence and structure of psychiatric diagnoses. By analyzing empirical findings and philosophical principles, the study seeks to inform clinicians and theorists about the complexities of psychiatric classification systems.